Cargando…
Risk and Factors associated with disease manifestations in systemic lupus erythematosus – lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients
OBJECTIVES: Lupus nephritis (LN) remains one of the most severe manifestations in patients with systemic lupus erythematosus (SLE). Onset and overall LN risk among SLE patients remains considerably difficult to predict. Utilizing a territory-wide longitudinal cohort of over 10 years serial follow-up...
Autores principales: | Chan, Shirley C. W., Wang, Yong-Fei, Yap, Desmond Y. H., Chan, Tak Mao, Lau, Yu Lung, Lee, Pamela P. W., Lai, Wai Ming, Ying, Shirley K. Y., Tse, Niko K. C., Leung, Alexander M. H., Mok, Chi Chiu, Lee, Ka Lai, Li, Teresa W. L., Tsang, Helen H. L., Yeung, Winnie W. Y., Ho, Carmen T. K., Wong, Raymond W. S., Yang, Wanling, Lau, Chak Sing, Li, Philip H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311203/ https://www.ncbi.nlm.nih.gov/pubmed/37398664 http://dx.doi.org/10.3389/fimmu.2023.1200732 |
Ejemplares similares
-
Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021) -
Systemic Lupus Erythematosus and Immunodeficiency
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021) -
B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
por: Yap, Desmond Y. H., et al.
Publicado: (2019) -
MicroRNAs in Lupus Nephritis–Role in Disease Pathogenesis and Clinical Applications
por: So, Benjamin Y. F., et al.
Publicado: (2021) -
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)